• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

China launches campaign to improve quality of medical treatment

www.gov.cnMarch 30, 2023

Tag: medical treatment , traditional Chinese medicine

Chinese health authorities have initiated a campaign to improve the quality and safety of medical treatment in medical institutions across the country.

An action plan for 2023 to 2025 was released by the National Health Commission and the National Administration of Traditional Chinese Medicine.

The three-year program will focus on strengthening the quality and safety management of medical treatment in emergency departments, outpatient departments and other areas of hospitals.

Special initiatives will be taken to improve the quality and safety of surgical operations, per the plan.

The day-to-day monitoring of medical treatment will also be carried out, it added.

Previous:China, New Zealand to further enhance science cooperation

Next:China accelerates AI application to real economy

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

China launches campaign to improve quality of medical treatment - PharmaSources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

ZYG series traditional Chinese medicine extract spray dryer

ZYG series traditional Chinese medicine extract spray dryer
YF Series Traditional Chinese Medicine Dust Collecting Crushing Set

YF Series Traditional Chinese Medicine Dust Collecting Crushing Set
Sanitary Stainless steel Low temperature vacuum traditional Chinese medicine extractor machines

Sanitary Stainless steel Low temperature vacuum traditional Chinese medicine extractor machines
HR/T16M Bench top High Speed cold laboratory centrifuge for medical treatment and public health

HR/T16M Bench top High Speed cold laboratory centrifuge for medical treatment and public health
traditional Chinese medicine vacuum belt dryer machine

traditional Chinese medicine vacuum belt dryer machine
ZLPG type traditional Chinese medicine extract spray drying unit

ZLPG type traditional Chinese medicine extract spray drying unit
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service